OBJECTIVES: To meet the continuing demand for PRO instruments in clinical research and practice more and more PRO instruments are being developed. Although the prerequisite for international pooling and comparison of data is an identifiable original instrument and an official translation in a given language, this is not always the case. The need to modify instruments and the emergence of item banks make it difficult to identify an original instrument and the access to it is complicated as international copyright law is not sufficiently clear on this point. The objective of this abstract is to review the issues encountered by our distribution centre when disseminating instruments and their translations in collaboration with their developers and to provide recommendations for those who wish to develop an instrument, access it, use and/or modify it. METHODS: To establish recommendations we proceeded as follows: 1) review of all requests to access, use and/ or modify an instrument or its translations; 2) classification of requests, and 3) recommendations. RESULTS: Out of the 2679 requests concerning PRO instruments in 2006, 6 types of questions emerge to what are the conditions to: 1) access; 2) translate; 3) reproduce; 4) use in e-application; 5) modify; 6) use selected items of a given instrument. In response to this international copyright law needs to be interpreted and solutions for conflicting laws across countries must be found. Concrete examples will be provided in the presentation. CONCLUSION: Despite its importance for clinical research the identification of and access to an original instrument and its translations is not easy. This is complicated by the emerging need to modify instruments and the absence of clear indications by international copyright law. Our findings indicate the importance of questionnaire distribution centres as a step in the direction of solving copyright issues.
Anfray C, Emery MP Mapi Research Trust, Lyon, France OBJECTIVES: To meet the continuing demand for PRO instruments in clinical research and practice more and more PRO instruments are being developed. Although the prerequisite for international pooling and comparison of data is an identifiable original instrument and an official translation in a given language, this is not always the case. The need to modify instruments and the emergence of item banks make it difficult to identify an original instrument and the access to it is complicated as international copyright law is not sufficiently clear on this point. The objective of this abstract is to review the issues encountered by our distribution centre when disseminating instruments and their translations in collaboration with their developers and to provide recommendations for those who wish to develop an instrument, access it, use and/or modify it. METHODS: To establish recommendations we proceeded as follows: 1) review of all requests to access, use and/ or modify an instrument or its translations; 2) classification of requests, and 3) recommendations. RESULTS: Out of the 2679 requests concerning PRO instruments in 2006, 6 types of questions emerge to what are the conditions to: 1) access; 2) translate; 3) reproduce; 4) use in e-application; 5) modify; 6) use selected items of a given instrument. In response to this international copyright law needs to be interpreted and solutions for conflicting laws across countries must be found. Concrete examples will be provided in the presentation. CONCLUSION: Despite its importance for clinical research the identification of and access to an original instrument and its translations is not easy. This is complicated by the emerging need to modify instruments and the absence of clear indications by international copyright law. Our findings indicate the importance of questionnaire distribution centres as a step in the direction of solving copyright issues.
PMC19 HOW GOOD IS GOOD ENOUGH? INTERNAL VALIDITY OF STATED PREFERENCES FOR DRUG THERAPIES
Ozdemir S, Mohamed AF, Huiber G, Johnson FR Research Triangle Institute, Research Triangle Park, NC, USA OBJECTIVES: To compare measures of internal validity across similar stated-choice surveys, evaluate consequences of inconsistencies, and determine whether there is a basis for establishing a minimum standard for validity. METHODS: Axioms of utility theory require that valid preferences be stable, monotonic, and transitive. Counts of validity failures were obtained for each survey respondent in 8 stated-choice or discrete-choice experiment surveys. Each survey was administered to adults who were diagnosed with a specific disease. Each survey required respondents to choose between 8 to 12 pairs of treatment alternatives with varying treatment features. We also identified respondents with non-compensatory or lexicographic preferences, where subjects choose alternatives based on a single attribute. Using negative-binomial regression we estimated the effect of personal characteristics on internal-validity test results. RESULTS: Choices from 3929 respondents were evaluated for internal validity. Across all surveys, approximately 20% failed at least one stability test, 10% failed at least one monotonicity test and 15% exhibited lexicographic preferences. Non-white respondents (p < 0.05) and respondents with less education (p < 0.05) were more likely to fail one of these tests. The effect of income is concave. As income increases the likelihood of failure of one or more tests decreases; however, above an annual income of $100,000, the likelihood of failure increases. Gender, age and employment had no significant effect on internal validity. With the exception of respondents with lexicographic preferences, removing respondents who fail internal validity tests generally did not materially change point estimates in preference models. However, removing inconsistent respondents improved estimate precision by 1-5%. CONCLUSION: Our results suggest that a failure of non-lexicographic internal validity tests at a rate less than 25% does not bias preference estimates derived from statedchoice surveys. Identifying which respondent groups find statedchoice surveys challenging can help in developing and pretesting surveys that minimize cognitive errors in those groups.
PMC20 CROSS-OVER RANDOMIZED CONTROL TRIAL OF ELECTRONIC MEASUREMENT OF HEALTH-RELATED QUALOITY OF LIFE IN
1 Zhejiang University, Hangzhou, China, 2 University of Goettingen, Goettingen, Germany OBJECTIVES: Verification of the feasibility and reliability of the electronic version of Chinese SF-36 (based on the Quality-ofLife-Recorder) before its wide deployment. METHODS: Crossover randomized controlled trial, comparing a paper based and an electronic version of the SF-36. According to generated random numbers, interviewees were asked to fill out either the electronic version or the paper version first. The second version was filled in after a pause of at least 30 minutes (medical students), or at least 10 minutes (patients). Convenience sample consisted of one group of 50 medical students and the other group of 100 patients. RESULTS: The acceptance of the electronic version was good (60% of medical students and 84% of patients preferred the electronic version). At the level of eightscale scores, the mean-difference for each scale (except for General Health) between the two versions was less than 5%. At the level of 36 questions, the percentage of "Exact Agreement" ranged within 64-99%; the percentage of "Global Agreement" ranged within 72-99%; 77% of the Kappa coefficients demonstrated "good/excellent agreement" and 23% of the Kappa coefficients demonstrated "medium agreement". CONCLUSION: Our findings support the feasibility and acceptance of an electronic version of the Chinese SF-36, as well as the agreement of results collected with paper-based and electronic version. The electronic versions may contribute to widespread deployment of this questionnaire.
PMC21 FEASIBILITY,VALIDITY AND RELIABILITY OF THE WELSH VERSION OF THE EQ-5D HEALTH STATUS QUESTIONNAIRE
Hughes D University of Wales, Bangor, Bangor, UK OBJECTIVES: To investigate the feasibility, validity and reliability of the Welsh language version of the EQ-5D in a random adult population sample in Welsh-speaking areas of Wales. METHODS: 1000 names were selected at random from electoral registries, and questionnaires that included the Welsh version of the EQ-5D together with questions on socio-economic, demographic and health status, were mailed. Subjects were asked to rate their health on the day of completion. Respondents to the first questionnaire were sent a second EQ-5D within a fortnight to assess test-retest reliability. A reminder was sent if the second questionnaire was not returned within a fortnight. A pre-paid envelope was provided in each case. The acceptability and feasibility was assessed by examining the number of missing responses on returned forms. A reliability analysis was conducted, following the test-retest procedure, and construct valid-ity was assessed in terms of convergent validity. RESULTS: 126 subjects returned the first questionnaire, of which 113 completed the second. Women represented 59.9% of the sample, and respondents' mean age was 56.8 +/− 18 years. 38.7% of subjects reported having chronic illness. The number of missing items from the descriptive EQ-5D (aggregated for both administrations) was 4, representing 0.33% of all responses. Five EQ-VAS responses were returned incomplete. 97 (85.8%) respondents reported no change in health in the fortnight between the first and second administration. The Spearman rank coefficients for these respondents were 0.828 for EQ-5D scores, and 0.815 for EQ-VAS, respectively (both p < 0.000). The results of the regression analysis for convergent validity suggested that, together, EQ-VAS score, self-reported health (5-point Likert scale; poor to excellent), presence of chronic illness, and receipt of treatment, explained 66.0% of the variation in EQ-5D scores. CONCLU-SION: It is concluded that the Welsh version of the EQ-5D has good acceptability, validity and reliability in measuring health status in subjects across Wales.
PMC22 TRADING HEALTH VALUES IN CHILE AND THE US USING EQ-5D
Kind An understanding of the exchange rate in health values is a necessary requirement to the transfer of health outcomes data across national borders. As a preliminary to studying the valuation data for EQ-5D health states in US and Chile it is useful to establish the comparability in values for selfreported health in the two countries. METHODS: EQ-5D is a generic, single index measure of health-related quality of life. It was included as part of a national valuation study conducted in the US in 2003 that elicited responses from a subgroup of 1216 Hispanics aged 18 and over. Similar data using EQ-5D was collected in a national survey of health in Chile (n = 4258). All respondents were assigned to a unique EQ-5D health state defined by their level of reported problem on the 5 dimensions. The mean visual analogue scale (VAS) score for each of these health states was computed from respondents' rating of their own health status on a 0-100 scale (EQ-5D VAS ). Mean EQ-5D VAS scores for each available EQ-5D health state were compared across the 2 country samples. RESULTS: The value of selfassessed health status was generally higher in the US Hispanic subgroup than for the same EQ-5D health state in the Chilean survey with a mean absolute difference of 8.5. A linear regression model used to examine the relationship between values for the most prevalent self-assessed health in the two countries took the form EQ-5D CHILE = 0.773*EQ-5D US-H + 10.301 CONCLU-SION: Should this relationship in values for self-classified EQ-5D health states prove to be stable, then it could be used as a conversion factor to estimate values for EQ-5D in Chile from values obtained from Hispanic respondents in the US national survey. Data from surveys reporting values for actual health states appear to be useful in recalibrating scales of value for hypothetical health states.
PMC23 CONSISTENCY OF MINIMAL IMPORTANT DIFFERENCES FOR MAPPED UTILITY INSTRUMENTS IN FOUR MAJOR PATIENT GROUPS
Nichol MB, Epstein JD, Dow TD University of Southern California, Los Angeles, CA, USA OBJECTIVES: It is unknown whether minimal important differences (MID) identified on generic patient reported outcomes are consistent across disease states. This research compares mapped utility instrument MID values within four newly identified patient groups. METHODS: Retrospective analysis of a two-year longitudinal study in a Western US managed care population was conducted. Individuals receiving a prescription for a new disease state in either year were selected. Four major disease states, each with more than 100 patients reporting a minimal change in health over the past year on the SF-36 general health question were included. MID values were calculated for gains and losses in health on the Brazier, Lundberg, Nichol, and Shmueli mapped utility instruments. MID values between disease groups for each instrument were tested with ANOVA. Effect sizes were compared in accordance to Norman (2001) as a distribution-based method to determine the MID. RESULTS: Results are displayed for Brazier's SF-6D measure as all mapped utility instruments had similar results. 145, 240, 306, and 150 patients reported a minimal gain or loss in health over the year when they filled a new prescription for cardiac disease, COPD, depression and rheumatoid arthritis, respectively. The reported mean MID utility change for gains was 0.026, 0.022, 0.019, and 0.018 for each patient group, respectively (P = 0.975). The reported mean MID utility change for losses was −0.069, −0.045, −0.055, and −0.028 for each patient group, respectively (P = 0.217). The average effect sizes ranged from 0.133 and 0.194 for gains and from −0.241 and −0.627 for losses. Therefore, according to Cohen's classification system, the MID values in gains were not significant changes, while those in losses were considered small. CONCLUSION: This data demonstrates consistent, but small, MID values across various disease groups for each utility instrument. Researchers should confirm results in other populations.
PMC24 PSYCHOMETRIC EVALUATION OF INSTRUMENTS USED TO MEASURE PATIENT SATISFACTION WITH PHARMACIST SERVICES
Rollins B, Franic DM University of Georgia, Athens, GA, USA OBJECTIVES: Evaluate the practical and psychometric properties of the instruments used to measure patient satisfaction with pharmacist cognitive services, including medication therapy management and patient counseling. METHODS: After a comprehensive literature review, instruments were included based on: at least one peer-reviewed publication using the instrument, reference lists, instrument availability, and a focus on pharmacist cognitive services. The six measurement criteria used were: practical features (administration time), breadth (multidimensional construct), depth (floor and ceiling effects), internal consistency (coefficient alpha > 0.7) and test-retest reliability (r > 0.7), and validity. Measurement evaluation was based on McHorney and Tarlov's (1995) criteria for evaluation of outcome measurements and the recent Food and Drug Administration guide on patient reported outcome measures (2006) . RESULTS: Of the 22 instruments identified, five were excluded because satisfaction was not measured as a multidimensional construct. Of the remaining 17 instruments, none met all six study criteria. A majority of the studies focused on patients' interaction with the pharmacist in a community pharmacy setting. Instruments were notable for the lack of reported psychometric data, especially test-retest reliability, which was reported in only one instrument. Only nine of 17 instruments reported internal consistency measures, but the nine reporting met study criteria (alpha > 0.7). The series of instruments developed by MacKeigan and Larson (1989, 1994, 
